Two bills now in the state Senate would clamp down on Pharmacy Benefit Managers, a kind of intermediary between drug companies and local pharmacies.

Aptar has a narrow economic moat, with durable switching costs in the Pharma business supported by intangible assets throughout the product portfolio from expertise in product regulation, design, and ...

California state senator Scott Wiener has introduced two bills, SB 40 and SB 41, to lower the cost of prescription drugs for ...

After more than three decades working as a constable for the District Court of Maryland, 78-year-old Thomas O’Rourke is one ...

Discover why people risk buying Ozempic and similar weight loss medications through social media, the devastating consequences, and legitimate ways to treatment ...

Congresswoman Nikki Budzinski (IL-13) introduced the Bringing Low-Cost Options and Competition while Keeping Incentives ...

We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

The spot “is a clear violation” of the FDCA, “which requires that advertising for prescription drugs — including compounded ...

For a century, Americans have embraced a punitive approach to addiction—one that has undermined treatment efforts.

The FDA has granted priority review to brensocatib to treat patients with non-cystic fibrosis bronchiectasis, according to a ...

The adjusted likelihood for an injurious fall in adults with COPD was elevated with a fall-risk increasing drug prescription, ...